Optimi Health Submits Phase I Clinical Trial Application Combining The Use Of…
<!-- Name:DistributionId Value:8744464 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Optimi Health
Alberta Puts Patients First By Regulating Psychedelic Therapy: Optimi Health
Highlights: The safe supply of psychedelic drug products manufactured at a GMP-level is critical in treating serious mental health issues. Minister of Mental Health and Addictions, the…
Optimi Health, ATMA Journey Centers To Proceed With Phase I Natural Psilocybin and…
VANCOUVER, British Columbia, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by…
Optimi Health Announces Canadian Retail and E-Commerce Distribution Agreements for…
VANCOUVER, British Columbia, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by…
Optimi Health Signs Psilocybin Supply Agreement With Halucenex Life Sciences Inc.
VANCOUVER, British Columbia, May 27, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company…